vs
POWER INTEGRATIONS INC（POWI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
POWER INTEGRATIONS INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$103.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 12.9%，领先371.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.1%）
Power Integrations Inc.是美国头部电力公用事业企业，业务覆盖美国本土11个州，服务超500万用户，在全美电力供应领域拥有领先的市场地位与成熟的运营体系。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
POWI vs RIGL — 直观对比
营收规模更大
POWI
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出23.1%
-1.9%
净利率更高
RIGL
高出371.2%
12.9%
两年增速更快
RIGL
近两年复合增速
6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $103.2M | $69.8M |
| 净利润 | $13.3M | $268.1M |
| 毛利率 | 52.9% | 91.5% |
| 营业利润率 | 8.5% | 33.2% |
| 净利率 | 12.9% | 384.0% |
| 营收同比 | -1.9% | 21.2% |
| 净利润同比 | 45.4% | 1769.2% |
| 每股收益（稀释后） | $0.24 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收POWIRIGL
| Q4 25 | $103.2M | $69.8M | ||
| Q3 25 | $118.9M | $69.5M | ||
| Q2 25 | $115.9M | $101.7M | ||
| Q1 25 | $105.5M | $53.3M | ||
| Q4 24 | $105.3M | $57.6M | ||
| Q3 24 | $115.8M | $55.3M | ||
| Q2 24 | $106.2M | $36.8M | ||
| Q1 24 | $91.7M | $29.5M |
净利润POWIRIGL
| Q4 25 | $13.3M | $268.1M | ||
| Q3 25 | $-1.4M | $27.9M | ||
| Q2 25 | $1.4M | $59.6M | ||
| Q1 25 | $8.8M | $11.4M | ||
| Q4 24 | $9.1M | $14.3M | ||
| Q3 24 | $14.3M | $12.4M | ||
| Q2 24 | $4.8M | $-1.0M | ||
| Q1 24 | $4.0M | $-8.2M |
毛利率POWIRIGL
| Q4 25 | 52.9% | 91.5% | ||
| Q3 25 | 54.5% | 93.2% | ||
| Q2 25 | 55.2% | 95.6% | ||
| Q1 25 | 55.2% | 91.7% | ||
| Q4 24 | 54.4% | 89.9% | ||
| Q3 24 | 54.5% | 85.5% | ||
| Q2 24 | 53.2% | 92.4% | ||
| Q1 24 | 52.1% | 93.1% |
营业利润率POWIRIGL
| Q4 25 | 8.5% | 33.2% | ||
| Q3 25 | -3.3% | 40.9% | ||
| Q2 25 | -1.2% | 60.1% | ||
| Q1 25 | 6.4% | 23.9% | ||
| Q4 24 | 3.7% | 28.9% | ||
| Q3 24 | 10.0% | 25.4% | ||
| Q2 24 | 1.8% | 1.2% | ||
| Q1 24 | 0.5% | -23.6% |
净利率POWIRIGL
| Q4 25 | 12.9% | 384.0% | ||
| Q3 25 | -1.1% | 40.2% | ||
| Q2 25 | 1.2% | 58.6% | ||
| Q1 25 | 8.3% | 21.5% | ||
| Q4 24 | 8.7% | 24.9% | ||
| Q3 24 | 12.3% | 22.5% | ||
| Q2 24 | 4.6% | -2.8% | ||
| Q1 24 | 4.3% | -27.9% |
每股收益（稀释后）POWIRIGL
| Q4 25 | $0.24 | $14.11 | ||
| Q3 25 | $-0.02 | $1.46 | ||
| Q2 25 | $0.02 | $3.28 | ||
| Q1 25 | $0.15 | $0.63 | ||
| Q4 24 | $0.15 | $0.82 | ||
| Q3 24 | $0.25 | $0.70 | ||
| Q2 24 | $0.09 | $-0.06 | ||
| Q1 24 | $0.07 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $249.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $672.8M | $391.5M |
| 总资产 | $772.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资POWIRIGL
| Q4 25 | $249.5M | $155.0M | ||
| Q3 25 | $241.9M | $137.1M | ||
| Q2 25 | $268.7M | $108.4M | ||
| Q1 25 | $289.3M | $77.1M | ||
| Q4 24 | $300.0M | $77.3M | ||
| Q3 24 | $303.8M | $61.1M | ||
| Q2 24 | $290.5M | $49.1M | ||
| Q1 24 | $299.6M | $49.5M |
总债务POWIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益POWIRIGL
| Q4 25 | $672.8M | $391.5M | ||
| Q3 25 | $672.0M | $117.6M | ||
| Q2 25 | $703.8M | $81.9M | ||
| Q1 25 | $735.8M | $18.6M | ||
| Q4 24 | $749.8M | $3.3M | ||
| Q3 24 | $749.2M | $-14.6M | ||
| Q2 24 | $730.7M | $-29.9M | ||
| Q1 24 | $738.2M | $-31.7M |
总资产POWIRIGL
| Q4 25 | $772.2M | $513.6M | ||
| Q3 25 | $772.5M | $242.5M | ||
| Q2 25 | $797.5M | $206.7M | ||
| Q1 25 | $814.4M | $176.0M | ||
| Q4 24 | $828.8M | $164.0M | ||
| Q3 24 | $825.0M | $139.4M | ||
| Q2 24 | $804.8M | $128.4M | ||
| Q1 24 | $805.8M | $126.5M |
负债/权益比POWIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $19.2M | — |
| 自由现金流率自由现金流/营收 | 18.6% | — |
| 资本支出强度资本支出/营收 | 6.8% | — |
| 现金转化率经营现金流/净利润 | 1.97× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $87.1M | — |
8季度趋势，按日历期对齐
经营现金流POWIRIGL
| Q4 25 | $26.2M | $22.0M | ||
| Q3 25 | $29.9M | $24.0M | ||
| Q2 25 | $29.1M | $30.5M | ||
| Q1 25 | $26.4M | $-893.0K | ||
| Q4 24 | $14.7M | $14.5M | ||
| Q3 24 | $32.9M | $21.7M | ||
| Q2 24 | $17.6M | $302.0K | ||
| Q1 24 | $15.9M | $-5.0M |
自由现金流POWIRIGL
| Q4 25 | $19.2M | — | ||
| Q3 25 | $24.2M | — | ||
| Q2 25 | $23.1M | — | ||
| Q1 25 | $20.7M | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $27.2M | — | ||
| Q2 24 | $13.5M | — | ||
| Q1 24 | $11.6M | — |
自由现金流率POWIRIGL
| Q4 25 | 18.6% | — | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | 20.0% | — | ||
| Q1 25 | 19.6% | — | ||
| Q4 24 | 11.1% | — | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q1 24 | 12.6% | — |
资本支出强度POWIRIGL
| Q4 25 | 6.8% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 4.7% | — |
现金转化率POWIRIGL
| Q4 25 | 1.97× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 21.24× | 0.51× | ||
| Q1 25 | 3.00× | -0.08× | ||
| Q4 24 | 1.61× | 1.01× | ||
| Q3 24 | 2.30× | 1.75× | ||
| Q2 24 | 3.64× | — | ||
| Q1 24 | 4.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
POWI
| Distributors | $65.8M | 64% |
| Other | $10.3M | 10% |
| KR | $9.3M | 9% |
| DE | $7.1M | 7% |
| TW | $5.5M | 5% |
| Emea Other Than Germany | $5.3M | 5% |
RIGL
暂无分部数据
